Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Neuropathol Appl Neurobiol ; 39(4): 348-61, 2013 Jun.
Article in English | MEDLINE | ID: mdl-22860626

ABSTRACT

AIMS: The prefrontal and anterior cingulate cortices are implicated in schizophrenia, and many studies have assessed volume, cortical thickness, and neuronal densities or numbers in these regions. Available data, however, are rather conflicting and no clear cortical alteration pattern has been established. Changes in oligodendrocytes and white matter have been observed in schizophrenia, introducing a hypothesis about a myelin deficit as a key event in disease development. METHODS: We investigated the dorsal anterior cingulate cortex (dACC) in 13 men with schizophrenia and 13 age- and gender-matched controls. We assessed stereologically the dACC volume, neuronal and glial densities, total neurone and glial numbers, and glia/neurone index (GNI) in both layers II-III and V-VI. RESULTS: We observed no differences in neuronal or glial densities. No changes were observed in dACC cortical volume, total neurone numbers, and total glial numbers in schizophrenia. This contrasts with previous findings and suggests that the dACC may not undergo as severe changes in schizophrenia as is generally believed. However, we observed higher glial densities in layers V-VI than in layers II-III in both controls and patients with schizophrenia, pointing to possible layer-specific effects on oligodendrocyte distribution during development. CONCLUSIONS: Using rigorous stereological methods, we demonstrate a seemingly normal cortical organization in an important neocortical area for schizophrenia, emphasizing the importance of such morphometric approaches in quantitative neuropathology. We discuss the significance of subregion- and layer-specific alterations in the development of schizophrenia, and the discrepancies between post mortem histopathological studies and in vivo brain imaging findings in patients.


Subject(s)
Cerebral Cortex/pathology , Gyrus Cinguli/pathology , Neuroglia/pathology , Neurons/pathology , Schizophrenia/pathology , Adult , Age of Onset , Cell Count , Demyelinating Diseases/pathology , Diagnostic and Statistical Manual of Mental Disorders , Humans , International Classification of Diseases , Male , Middle Aged , Oligodendroglia/pathology , Schizophrenic Psychology , Young Adult
2.
Neuroscience ; 112(1): 75-91, 2002.
Article in English | MEDLINE | ID: mdl-12044473

ABSTRACT

Although the presence of amyloid deposits is required to establish the neuropathologic diagnosis of Alzheimer's disease, from a clinical point of view, a direct contribution of these cerebral lesions to cognitive deficits is still controversial. The development and standardization of quantitative and accurate biochemical and neuropathologic methods may be critical to improve the postmortem diagnosis and clinicopathologic correlations. Here, we used a point counting method, based on the Cavalieri principle, to estimate the volume occupied by amyloid deposits in a discrete region of the prefrontal cortex and in the hippocampal formation, in brains from patients with cognitive status ranging from normal to severely demented. We demonstrate that the assessment of the total volume occupied by the amyloid deposits in the entorhinal cortex and subiculum can be considered an effective predictor of dementia severity. We also reveal the existence of a high degree of regional and interindividual heterogeneity in amyloid distribution and relative volume. Our data suggest that even though a correlation was observed between the stereologic point counting method and a non-stereologic random field thresholding approach, in most cases non-stereologic methods may not provide adequate samples of the tissue and may lead to unreliable estimates of amyloid burden due to the inhomogeneous distribution of amyloid in the cerebral cortex and the large variability among brains.


Subject(s)
Aging/metabolism , Aging/psychology , Alzheimer Disease/metabolism , Alzheimer Disease/psychology , Amyloid/metabolism , Cerebral Cortex/metabolism , Cognition , Aged , Aged, 80 and over , Alzheimer Disease/pathology , Biochemistry/methods , Cerebral Cortex/pathology , Densitometry , Hippocampus/metabolism , Humans , Middle Aged , Prefrontal Cortex/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...